Equities

Oncology Institute Inc

TOI:NAQ

Oncology Institute Inc

Actions
Health CareHealth Care Providers
  • Price (USD)0.154
  • Today's Change-0.001 / -0.65%
  • Shares traded7.03m
  • 1 Year change-92.34%
  • Beta0.4940
Data delayed at least 15 minutes, as of Nov 22 2024 21:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments8374114
Total Receivables, Net434021
Total Inventory149.266.44
Prepaid expenses4.056.9211
Other current assets, total--00.88
Total current assets143130154
Property, plant & equipment, net40334.19
Goodwill, net7.232127
Intangibles, net181818
Long term investments058--
Note receivable - long term------
Other long term assets0.560.480.32
Total assets209262203
LIABILITIES
Accounts payable149.3716
Accrued expenses171711
Notes payable/short-term debt000
Current portion long-term debt/capital leases--00.18
Other current liabilities, total3.603.493.36
Total current liabilities353030
Total long term debt87810
Total debt87810.18
Deferred income tax0.030.110.37
Minority interest------
Other liabilities, total312869
Total liabilities15213899
SHAREHOLDERS EQUITY
Common stock0.010.010.01
Additional paid-in capital204186167
Retained earnings (accumulated deficit)(146)(63)(63)
Treasury stock - common(1.02)----
Unrealized gain (loss)------
Other equity, total------
Total equity57123104
Total liabilities & shareholders' equity209262203
Total common shares outstanding747373
Treasury shares - common primary issue1.7300
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.